Magnesium hexacyanoferrate nanocatalysts attenuate chemodrug-induced cardiotoxicity through an anti-apoptosis mechanism driven by modulation of ferrous iron

[1]  L. Brunham,et al.  Regulated cell death pathways in doxorubicin-induced cardiotoxicity , 2021, Cell Death & Disease.

[2]  D. Schwarzer,et al.  Time-Resolved Spectroscopy of Photoinduced Electron Transfer in Dinuclear and Tetranuclear Fe/Co Prussian Blue Analogues. , 2020, Inorganic Chemistry.

[3]  D. Riley,et al.  Pd Ion‐Exchange and Ammonia Etching of a Prussian Blue Analogue to Produce a High‐Performance Water‐Splitting Catalyst , 2020, Advanced Functional Materials.

[4]  Yili Yang,et al.  A Nanozyme‐Based Artificial Peroxisome Ameliorates Hyperuricemia and Ischemic Stroke , 2020, Advanced Functional Materials.

[5]  Yan Jin,et al.  Treatment of infarcted heart tissue via the capture and local delivery of circulating exosomes through antibody-conjugated magnetic nanoparticles , 2020, Nature Biomedical Engineering.

[6]  J. Colet,et al.  GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells , 2020, Cells.

[7]  M. Hémadi,et al.  Tissue damage from neutrophil-induced oxidative stress in COVID-19 , 2020, Nature Reviews Immunology.

[8]  J. Kaiser A colorful chemotherapy agent could be made less toxic. , 2020, Science.

[9]  L. Miao,et al.  Integrated cascade nanozyme catalyzes in vivo ROS scavenging for anti-inflammatory therapy , 2020, Science Advances.

[10]  G. Pontone,et al.  Early diagnosis of chemotherapy-induced cardiotoxicity by cardiac MRI. , 2020, European journal of radiology.

[11]  C. Mummery,et al.  Uncoupling DNA damage from chromatin damage to detoxify doxorubicin , 2020, Proceedings of the National Academy of Sciences.

[12]  Xiaoyuan Chen,et al.  Ultrasmall copper-based nanoparticles for reactive oxygen species scavenging and alleviation of inflammation related diseases , 2020, Nature Communications.

[13]  Xian‐Zheng Zhang,et al.  Tumor‐Microenvironment‐Triggered Ion Exchange of a Metal–Organic Framework Hybrid for Multimodal Imaging and Synergistic Therapy of Tumors , 2020, Advanced materials.

[14]  Dean P. Jones,et al.  Reactive oxygen species (ROS) as pleiotropic physiological signalling agents , 2020, Nature Reviews Molecular Cell Biology.

[15]  Heliang Yao,et al.  Copper‐Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification , 2020, Advanced materials.

[16]  Tianfeng Chen,et al.  Highly bioactive zeolitic imidazolate framework-8–capped nanotherapeutics for efficient reversal of reperfusion-induced injury in ischemic stroke , 2020, Science Advances.

[17]  Wei Li,et al.  Bioinspired Construction of a Nanozyme-Based H2O2 Homeostasis Disruptor for Intensive Chemodynamic Therapy. , 2020, Journal of the American Chemical Society.

[18]  J. Colet,et al.  New Insights About Doxorubicin-Induced Toxicity to Cardiomyoblast-Derived H9C2 Cells and Dexrazoxane Cytoprotective Effect: Contribution of In Vitro 1H-NMR Metabonomics , 2020, Frontiers in Pharmacology.

[19]  Yuanjian Zhang,et al.  Copper Tannic Acid Coordination Nanosheet: A Potent Nanozyme for Scavenging ROS from Cigarette Smoke. , 2020, Small.

[20]  V. Karamyan,et al.  Intraperitoneal Route of Drug Administration: Should it Be Used in Experimental Animal Studies? , 2019, Pharmaceutical Research.

[21]  Hangrong Chen,et al.  Self-assembly hollow manganese Prussian white nanocapsules attenuate Tau-related neuropathology and cognitive decline. , 2019, Biomaterials.

[22]  G. El Fakhri,et al.  Renal clearable nanochelators for iron overload therapy , 2019, Nature Communications.

[23]  S. Yusuf,et al.  Cardiotoxicity Related to Radiation Therapy. , 2019, Cardiology clinics.

[24]  Yong Tang,et al.  miR-146a attenuates apoptosis and modulates autophagy by targeting TAF9b/P53 pathway in doxorubicin-induced cardiotoxicity , 2019, Cell Death & Disease.

[25]  M. Nguyen,et al.  Metal Ions in Alzheimer's Disease: A Key Role or Not? , 2019, Accounts of chemical research.

[26]  M. Conrad,et al.  Broken hearts: Iron overload, ferroptosis and cardiomyopathy , 2019, Cell Research.

[27]  Valerie A Longo,et al.  FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels , 2019, Nature Nanotechnology.

[28]  D. Butterfield,et al.  Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease , 2019, Nature Reviews Neuroscience.

[29]  F. Gao,et al.  Ferroptosis as a target for protection against cardiomyopathy , 2019, Proceedings of the National Academy of Sciences.

[30]  Changlong Hao,et al.  Chiral Molecule-mediated Porous Cu xO Nanoparticle Clusters with Antioxidation Activity for Ameliorating Parkinson's Disease. , 2018, Journal of the American Chemical Society.

[31]  Robin L. Jones,et al.  Risk-benefit of dexrazoxane for preventing anthracycline-related cardiotoxicity: re-evaluating the European labeling. , 2018, Future oncology.

[32]  Songping D. Huang,et al.  KCa(H2 O)2 [FeIII (CN)6 ]⋅H2 O Nanoparticles as an Antimicrobial Agent against Staphylococcus aureus. , 2018, Angewandte Chemie.

[33]  P. Austin,et al.  A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer , 2017, JAMA cardiology.

[34]  Yu Zhang,et al.  Prussian Blue Nanoparticles as Multienzyme Mimetics and Reactive Oxygen Species Scavengers. , 2016, Journal of the American Chemical Society.

[35]  Elizabeta Nemeth,et al.  Iron homeostasis in host defence and inflammation , 2015, Nature reviews. Immunology.

[36]  Michael S. Ewer,et al.  Cardiotoxicity of anticancer treatments , 2015, Nature Reviews Cardiology.

[37]  M. Beal,et al.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.

[38]  N. Vaziri,et al.  Mechanisms of Disease: oxidative stress and inflammation in the pathogenesis of hypertension , 2006, Nature Clinical Practice Nephrology.

[39]  J. Andersen,et al.  Oxidative stress in neurodegeneration: cause or consequence? , 2004, Nature Reviews Neuroscience.